Fourteen game-changing biotech companies to know in Germany
The German biotech ecosystem is well established despite the challenges it is facing. Discover fourteen key Germany-based biotech companies.| Labiotech.eu
The German biotech ecosystem is well established despite the challenges it is facing. Discover fourteen key Germany-based biotech companies.| Labiotech.eu
Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer.| Labiotech.eu
From groundbreaking immunotherapies to AI diagnostics and new vaccines, explore the innovations shaping the future of cancer treatment.| Labiotech.eu
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?| Labiotech.eu
On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round.| Labiotech.eu
